Skip directly to site content Skip directly to search


Español  Other Languages


Centers for Disease Control and Prevention. CDC twenty four seven. Saving Lives, Protecting People
 Search
		×
			NIOSH
			NIOSH
				All CDC
				Submit
			For a full list of topics:A-Z Index
			Advanced Search
		Advanced Search


The National Institute for Occupational Safety and Health (NIOSH)








Respiratory and Immunologic Evaluation of Isocyanate Exposure in a New Manufacturing Plant						Print
																Related Pages
										June 1981
DHHS (NIOSH) Publication Number 81-125
81-125 Cover
The long term respiratory and immunologic effects of occupational exposure to toluene-diisocyanate (584849) (TDI) were studied in humans. A total of 277 production workers in a TDI manufacturing facility completed respiratory and health questionnaires and were examined spirometrically and immunologically before initial TDI exposure and at various intervals during 5.5 years of continuous or intermittent occupational exposure. Cumulative exposure for each worker was measured by personal samples, and those exposed to an average of 0.0682 part per million months (ppm/month) or less were classified as Group 1, while workers exposed to higher concentration were designated Group 2. About 4 percent of the exposed workers developed bronchial hypersensitivity to TDI, and 75 percent of reactive workers developed their sensitivity within 9 months of initial exposure. During about 0.8, 3.0, and 14.6 percent of total occupational exposure time, atmospheric TDI concentrations were above 0.08, 0.02, and 0.005ppm, respectively. The average annual decline in forced expiratory volume (FEV) for all exposed workers was 24 milliliters (ml), not significantly different from FEV decline in nonexposed smoker populations. The mean FEV decline in Group 2 workers who had never smoked was 38ml greater than the mean FEV decline in Group 1 employees who had never smoked. The average declines in single breath carbon-monoxide diffusing capability and in median forced expiratory flow were significantly different from control for both groups, and these pulmonary function decreases were related to cumulative TDI exposure. Immunologic reactivity to TDI exposure occurred in about 4 percent of all exposed workers. The authors conclude that the respiratory effects of TDI exposure are masked in smokers but are significant in nonsmokers.
Respiratory and Immunologic Evaluation of Isocyanate Exposure in a New Manufacturing Plant [PDF – 10 MB]
							
					
							Last Reviewed:  April 5, 2017						Source: 	National Institute for Occupational Safety and Health
					Facebook
        Twitter
        LinkedIn
        Syndicate homeNIOSH Publications & Products
NIOSH-Issued Publications
Search NIOSHTIC-2 Research Database
Docket
Documents for Public Review
Peer Review Agenda
Databases
eNews
Federal Register Noticesplus icon
FRN Archive 2007-2010
FRN Archive 2005-2006
FRN Archive 2001-2004
FRN Archive 1996-2000
Press Releases and Updatesplus icon
Press Release Archives 2010-2013
Press Release Archives 2006-2009
Press Release Archives 2001-2005
Press Release Archives 1998-2000
Press Release Archives 1992-1997
Regulations
Regulatory Agenda
Science Blog
Software
Video Follow NIOSH Facebook
Pinterest
Twitter
YouTube
 NIOSH Homepage NIOSH A-Z
Workplace Safety & Health Topics
Publications and Products
Programs
Contact NIOSH


About CDC
					Contact Us
					800-232-4636
 Facebook Twitter Instagram LinkedIn Youtube Pinterest Snapchat
 CONTACT CDC
				Contact Us
							Call 800-232-4636
							Email Us
			ABOUT CDC
				About CDC
							Jobs
							Funding
			POLICIES
				Accessibility
							External Links
							Privacy
							Policies
							No Fear Act
							FOIA
							OIG
							Nondiscrimination
							Vulnerability Disclosure Policy
			CONNECT WITH US
				Facebook
								Twitter
								Instagram
								LinkedIn
							Youtube
								Pinterest
								Snapchat
								Email
			LANGUAGES
				Español
							繁體中文
							Tiếng Việt
							한국어
							Tagalog
							Русский
							العربية
							Kreyòl Ayisyen
							Français
							Polski
							Português
							Italiano
							Deutsch
							日本語
							فارسی
							English


U.S. Department of Health & Human Services
			Accessibility
			External Links
			Privacy
			Policies
			No Fear Act
			FOIA
			Nondiscrimination
			OIG
			Vulnerability Disclosure Policy
			USA.gov


Exit Notification / Disclaimer Policy Close
 Links with this icon  indicate that you are leaving the CDC website. The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
				Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
				You will be subject to the destination website's privacy policy when you follow the link.
				CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website. Website Disclaimers
 Cancel Continue